In the BioHarmony Drug Report Database

"Preview" Icon

Apixaban

Eliquis (apixaban) is a small molecule pharmaceutical. Apixaban was first approved as Eliquis on 2011-05-18. It is used to treat pulmonary embolism and venous thrombosis in the USA. It has been approved in Europe to treat arthroplasty, stroke, and venous thromboembolism. The pharmaceutical is active against coagulation factor X. Eliquis’s patents are valid until 2031-02-24 (FDA).

 

Trade Name

 

Eliquis
 

Common Name

 

apixaban
 

ChEMBL ID

 

CHEMBL231779
 

Indication

 

arthroplasty, pulmonary embolism, stroke, venous thromboembolism, venous thrombosis
 

Drug Class

 

Antithrombotic: blood coagulation factor XA inhibitors

Image (chem structure or protein)

Apixaban structure rendering